Drugs / Rotarix vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01700621 | Jan → Sep 2013 | Rotavirus infection | PATH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rotarix vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01700621 ↗ |
| Modality | Vaccine | “a third dose of human rotavirus vaccine (HRV; MR + HRV)” PMID 26823338 ↗ Jan 2016 |
| Route | Oral | “one 1.0 ml dose of oral rotavirus vaccine at 9 months of age” NCT01700621 ↗ |